178 related articles for article (PubMed ID: 22372675)
21. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006).
Stefanello D; Morello E; Roccabianca P; Iussich S; Nassuato C; Martano M; Squassino C; Avallone G; Romussi S; Buracco P
Vet Surg; 2008 Jul; 37(5):461-5. PubMed ID: 18986313
[TBL] [Abstract][Full Text] [Related]
22. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
McSporran KD
Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
[TBL] [Abstract][Full Text] [Related]
23. Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.
Avallone G; Stefanello D; Boracchi P; Ferrari R; Gelain ME; Turin L; Tresoldi E; Roccabianca P
Vet Pathol; 2015 Nov; 52(6):1034-40. PubMed ID: 25795373
[TBL] [Abstract][Full Text] [Related]
24. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
25. Preliminary study of plasma vascular endothelial growth factor (VEGF) during low- and high-dose radiation therapy of dogs with spontaneous tumors.
Wergin MC; Ballmer-Hofer K; Roos M; Achermann RE; Inteeworn N; Akens MK; Blattmann H; Kaser-Hotz B
Vet Radiol Ultrasound; 2004; 45(3):247-54. PubMed ID: 15200265
[TBL] [Abstract][Full Text] [Related]
26. Canine distal hindlimb soft tissue sarcoma--a novel approach to surgical defect closure.
Fourie Y; Heidenreich D; Barreau P
Vet Comp Orthop Traumatol; 2011; 24(1):84-8. PubMed ID: 21103654
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of pre-treatment biopsy for grading soft tissue sarcomas in dogs.
Perry JA; Culp WT; Dailey DD; Eickhoff JC; Kamstock DA; Thamm DH
Vet Comp Oncol; 2014 Jun; 12(2):106-13. PubMed ID: 22617002
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of thrombospondin-1 mimetic peptides, ABT-510 and ABT-898, in dogs with soft tissue sarcoma.
Sahora AI; Rusk AW; Henkin J; McKeegan EM; Shi Y; Khanna C
J Vet Intern Med; 2012; 26(5):1169-76. PubMed ID: 22816494
[TBL] [Abstract][Full Text] [Related]
29. Aqueous humor vascular endothelial growth factor in dogs: association with intraocular disease and the development of pre-iridal fibrovascular membrane.
Sandberg CA; Herring IP; Huckle WR; LeRoith T; Pickett JP; Rossmeisl JH
Vet Ophthalmol; 2012 Mar; 15 Suppl 1():21-30. PubMed ID: 22050642
[TBL] [Abstract][Full Text] [Related]
30. Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma.
Oda Y; Tateishi N; Matono H; Matsuura S; Yamamaoto H; Tamiya S; Yokoyama R; Matsuda S; Iwamoto Y; Tsuneyoshi M
Int J Cancer; 2009 Apr; 124(8):1852-9. PubMed ID: 19107931
[TBL] [Abstract][Full Text] [Related]
31. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
[TBL] [Abstract][Full Text] [Related]
32. Surgery and electrochemotherapy of a high-grade soft tissue sarcoma in a dog.
Spugnini EP; Vincenzi B; Betti G; Cordahi F; Dotsinsky I; Mudrov N; Citro G; Baldi A
Vet Rec; 2008 Feb; 162(6):186-8. PubMed ID: 18263920
[No Abstract] [Full Text] [Related]
33. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
34. Endostatin and vascular endothelial growth factor concentrations in healthy dogs, dogs with selected neoplasia, and dogs with nonneoplastic diseases.
Troy GC; Huckle WR; Rossmeisl JH; Panciera D; Lanz O; Robertson JL; Ward DL
J Vet Intern Med; 2006; 20(1):144-50. PubMed ID: 16496934
[TBL] [Abstract][Full Text] [Related]
35. Principles of treatment for soft tissue sarcoma.
Dernell WS; Withrow SJ; Kuntz CA; Powers BE
Clin Tech Small Anim Pract; 1998 Feb; 13(1):59-64. PubMed ID: 9634350
[TBL] [Abstract][Full Text] [Related]
36. Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma.
Kamstock D; Guth A; Elmslie R; Kurzman I; Liggitt D; Coro L; Fairman J; Dow S
Cancer Gene Ther; 2006 Mar; 13(3):306-17. PubMed ID: 16138118
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas.
Potti A; Ganti AK; Foster H; Knox S; Hebert BJ; Tendulkar K; Sholes K; Koch M; Kargas S
Anticancer Res; 2004; 24(1):333-7. PubMed ID: 15015617
[TBL] [Abstract][Full Text] [Related]
38. Canine soft tissue sarcoma managed in first opinion practice: outcome in 350 cases.
Bray JP; Polton GA; McSporran KD; Bridges J; Whitbread TM
Vet Surg; 2014 Oct; 43(7):774-82. PubMed ID: 24724565
[TBL] [Abstract][Full Text] [Related]
39. Expression of VEGF and its receptors and angiogenesis in bone and soft tissue tumors.
Hara H; Akisue T; Fujimoto T; Imabori M; Kawamoto T; Kuroda R; Fujioka H; Yamamoto T; Doita M; Kurosaka M
Anticancer Res; 2006; 26(6B):4307-11. PubMed ID: 17201149
[TBL] [Abstract][Full Text] [Related]
40. Radiation as a therapeutic modality in sarcomas of the soft tissue.
Suit H; Spiro I
Hematol Oncol Clin North Am; 1995 Aug; 9(4):733-46. PubMed ID: 7490238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]